Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7182

1.

[Presence of lactoferrin in faeces as the indicator of Clostridium difficile in pediatric patients].

Dąbrowskal S, Demkow U, Podsiadły E.

Med Dosw Mikrobiol. 2015;67(1):1-8. Polish.

PMID:
26084069
2.

Cloning and variation of ground state intestinal stem cells.

Wang X, Yamamoto Y, Wilson LH, Zhang T, Howitt BE, Farrow MA, Kern F, Ning G, Hong Y, Khor CC, Chevalier B, Bertrand D, Wu L, Nagarajan N, Sylvester FA, Hyams JS, Devers T, Bronson R, Lacy DB, Ho KY, Crum CP, McKeon F, Xian W.

Nature. 2015 Jun 11;522(7555):173-8. doi: 10.1038/nature14484. Epub 2015 Jun 3.

PMID:
26040716
3.

Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.

LaFrance ME, Farrow MA, Chandrasekaran R, Sheng J, Rubin DH, Lacy DB.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7073-8. doi: 10.1073/pnas.1500791112. Epub 2015 May 18.

PMID:
26038560
4.

[Frequency, clinical evolution and prognosis of toxic megacolon].

Magallón-Tapia M, Ceniceros RA, Arenas-Osuna J, Juarez-Leal CL, Peralta-Amaro AL.

Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 1:S88-93. Spanish.

PMID:
26020671
5.

Update on antimicrobial resistance in Clostridium difficile.

Qiong G, Haihui H.

Yi Chuan. 2015 May;37(5):458-64. doi: 10.16288/j.yczz.15-131. Review.

PMID:
25998434
6.

Treatment for Clostridium difficile infection in adults--reply.

Rao K, Bagdasarian N, Malani PN.

JAMA. 2015 May 19;313(19):1976. doi: 10.1001/jama.2015.3674. No abstract available.

PMID:
25988472
7.

Treatment for Clostridium difficile infection in adults.

Dai C, Jiang M, Sun MJ.

JAMA. 2015 May 19;313(19):1975-6. doi: 10.1001/jama.2015.3671. No abstract available.

PMID:
25988470
8.

Treatment for Clostridium difficile infection in adults.

McDonald EG, Lee TC.

JAMA. 2015 May 19;313(19):1974-5. doi: 10.1001/jama.2015.3668. No abstract available.

PMID:
25988469
9.

Selected aspects of Clostridium difficile infection.

Mehlich A, Górska S, Gamian A, Myc A.

Postepy Hig Med Dosw (Online). 2015 May 5;69(0):598-611. doi: 10.5604/17322693.1151340.

PMID:
25983298
10.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S.

JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.

PMID:
25942722
11.

A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.

Anosova NG, Cole LE, Li L, Zhang J, Brown AM, Mundle S, Zhang J, Ray S, Ma F, Garrone P, Bertraminelli N, Kleanthous H, Anderson SF.

Clin Vaccine Immunol. 2015 Jul;22(7):711-25. doi: 10.1128/CVI.00763-14. Epub 2015 Apr 29.

PMID:
25924765
12.

The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties.

Pantaléon V, Soavelomandroso AP, Bouttier S, Briandet R, Roxas B, Chu M, Collignon A, Janoir C, Vedantam G, Candela T.

PLoS One. 2015 Apr 29;10(4):e0124971. doi: 10.1371/journal.pone.0124971. eCollection 2015.

13.

Oral teicoplanin (TARGOCID) and intestinal Clostridium difficile infection. Just another option.

[No authors listed]

Prescrire Int. 2015 Mar;24(158):67. No abstract available.

PMID:
25897455
14.

Fecal transplantation to treat initial severe Clostridium difficile infection with sepsis.

Marcos LA, Gersh A, Blanchard K, Foil S, Mallini B, Farrell SE, Kahler R.

J Miss State Med Assoc. 2015 Feb;56(2):38-40. No abstract available.

PMID:
25895282
15.

Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).

Hemmasi S, Czulkies BA, Schorch B, Veit A, Aktories K, Papatheodorou P.

J Biol Chem. 2015 May 29;290(22):14031-44. doi: 10.1074/jbc.M115.650523. Epub 2015 Apr 16.

PMID:
25882847
16.

Toward a true bacteriotherapy for Clostridium difficile infection.

Rupnik M.

N Engl J Med. 2015 Apr 16;372(16):1566-8. doi: 10.1056/NEJMcibr1500270. No abstract available.

PMID:
25875262
17.

Clostridium difficile infection.

Leffler DA, Lamont JT.

N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772. Review. No abstract available.

PMID:
25875259
18.

Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.

Stollman N, Smith M, Giovanelli A, Mendolia G, Burns L, Didyk E, Burgess J, Noh A, Edelstein C, Alm E, Kassam Z.

Am J Gastroenterol. 2015 Apr;110(4):600-1. doi: 10.1038/ajg.2015.81. No abstract available.

PMID:
25853204
19.

The economic impact of Clostridium difficile infection: a systematic review.

Nanwa N, Kendzerska T, Krahn M, Kwong JC, Daneman N, Witteman W, Mittmann N, Cadarette SM, Rosella L, Sander B.

Am J Gastroenterol. 2015 Apr;110(4):511-9. doi: 10.1038/ajg.2015.48. Epub 2015 Apr 7. Review.

PMID:
25848925
20.

[Clostridium difficile colitis].

Eckert C, Lalande V, Barbut F.

Rev Prat. 2015 Jan;65(1):21-5. Review. French.

PMID:
25842418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk